CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Apple Watchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04510779
NCT04510779N/ACompleted
CompareCT.gov

Monitoring Heart Failure Patients Using Heart Rate Variability Measured by the Apple Watch

Tufts Medical Center·interventional·Posted Aug 12, 2020·Updated Jun 5, 2024

In Brief

A clinical study evaluating Apple Watch for Heart Failure. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This is a pilot/feasibility study on the accuracy of HRV as measured by the Apple Watch on heart failure patients who are admitted to the hospital with heart failure exacerbation. The primary aim is to observe a statistically significant improvement in the HRV of acutely decompensated heart failure patients upon discharge when compared to admission, implying the utility of HRV measured by Apple Watch as a monitor for cardiovascular health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 12, 2020
Enrollment StartMay 9, 2022
Primary CompletionNov 30, 2023
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.9 years ago

Interventions

Apple Watchdevice

Apple Watch is a smartwatch developed by Apple Inc. The heart rate variability function will be used.